LOS ANGELES--(BUSINESS WIRE)--
The Law Offices of Todd M. Garber announces that it is investigating potential claims against Chemed Corporation (“Chemed” or the “Company”) (CHE) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company between February 26, 2010 and May 2, 2013 regarding Chemed’s business, operations and prospects.
Chemed, through its subsidiaries, operates in the healthcare, and repair and maintenance fields in the United States. The Company’s Vitas segment offers hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The investigation is related to the May 2, 2013 disclosure that the United States Department of Justice (“DOJ”) had filed a lawsuit under the federal False Claims Act against Chemed and its affiliates alleging that the Company systematically defrauded Medicare. The DOJ’s complaint alleges that Chemed billed Medicare for unnecessary and fraudulent treatments, including billing for hospice care for patients who were not terminally ill. As a result of this news, shares of Chemed declined more than 15%.
If you purchased Chemed shares, if you have information or would like to learn more about these claims, or if you purchased shares prior to February 26, 2010 and have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Todd M. Garber, Esquire, of the Law Offices of Todd M. Garber, by telephone at 213-700-7262 or by email to info@toddgarberlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
